首页> 美国卫生研究院文献>Scientific Reports >Allostimulatory capacity of conditionally immortalized proximal tubule cell lines for bioartificial kidney application
【2h】

Allostimulatory capacity of conditionally immortalized proximal tubule cell lines for bioartificial kidney application

机译:条件永生的近端肾小管细胞系对生物人工肾的同种刺激能力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Novel renal replacement therapies, such as a bioartificial kidney (BAK), are needed to improve current hemodialysis treatment of end-stage renal disease (ESRD) patients. As BAK applications may reveal safety concerns, we assessed the alloimmunization and related safety aspects of readily available conditionally immortalized human proximal tubule epithelial cell (ciPTEC) lines to be used in BAK. Two ciPTEC lines, originally derived from urine and kidney tissue, were characterized for the expression and secretion of relevant molecules involved in alloimmunization and inflammatory responses, such as HLA class-I, HLA-DR, CD40, CD80, CD86, as wells as soluble HLA class I and proinflammatory cytokines (IL-6, IL-8 and TNF-α). A lack of direct immunogenic effect of ciPTEC was shown in co-culture experiments with peripheral blood mononuclear cells (PBMC), after appropriate stimulation of ciPTEC. Tight epithelial cell monolayer formation on polyethersulfone flat membranes was confirmed by zonula occludens-1 (ZO-1) expression in the ciPTEC tight junctions, and by restricted inulin-FITC diffusion. Co-culture with (activated) PBMC did not jeopardize the transepithelial barrier function of ciPTEC. In conclusion, the absence of allostimulatory effects and the stability of ciPTEC monolayers show that these unique cells could represent a safe option for BAK engineering application.
机译:需要新的肾脏替代疗法,例如生物人工肾(BAK),以改善当前对终末期肾脏疾病(ESRD)患者的血液透析治疗。由于BAK的应用可能显示出安全隐患,因此我们评估了将用于BAK的随时可用的有条件永生化的人类近端肾小管上皮细胞(ciPTEC)系的同种免疫和相关安全方面。表征了两个最初源自尿液和肾脏组织的ciPTEC品系,用于表达和分泌参与同种免疫和炎症反应的相关分子,例如HLA I类,HLA-DR,CD40,CD80,CD86以及可溶性HLA I类和促炎细胞因子(IL-6,IL-8和TNF-α)。在适当刺激ciPTEC后,与外周血单核细胞(PBMC)的共培养实验表明ciPTEC没有直接的免疫原性作用。聚醚砜平板膜上紧密的上皮细胞单层形成已通过ciPTEC紧密连接中的小带咬合蛋白1(ZO-1)表达以及限制性的菊粉-FITC扩散证实。与(活化的)PBMC共培养不会损害ciPTEC的跨上皮屏障功能。总之,缺少同种异体刺激作用和ciPTEC单层膜的稳定性表明,这些独特的细胞可以代表BAK工程应用的安全选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号